Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bloomway AI Announces Public Beta of CinePro: Infusing Cinematic Expertise into AIGC to Redefine the "Lean Cinema" Workflow
-
Bloomway AI Announces Public Beta of CinePro: Infusing Cinematic Expertise into AIGC to Redefine the "Lean Cinema" Workflow
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer
-
CytomX’s Varsetatug Masetecan (EpCAM PROBODY® ADC) Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer
-
GFM Announces Non-Brokered Private Placement
-
Nuclear Vision Acquires Manganese Carbonate Projects in Slovakia’s “Battery Belt”
-
REPEAT - Media Advisory: Concerned residents mount protests outside Liberal MP offices nationwide for action against the threat of U.S. private health care
-
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
-
Wallbridge Mining Announces Drilling Has Commenced at Martiniere
-
Monte Rosa Therapeutics Announces Clinical Supply Agreement to Support Phase 2 Trial Evaluating MRT-2359 in Combination with Apalutamide for the Treatment of Metastatic Castration-Resistant Prostate C
-
Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026
-
Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron
-
Tower Semiconductor Teams up with Oriole to Advance AI Infrastructure and Networking with Nanosecond Optical Circuit Switching
-
Aurora Mobile Establishes Japanese Subsidiary to Redefine AI-Powered Customer Interaction and Security
-
NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting
-
Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine
-
Tilray Brands Enters Agreement to Acquire BrewDog’s Key U.S. Assets, Expanding Its U.S. Craft Beer Platform
-
Plug Executive Leadership to Participate in Investor Conferences in Europe and Washington, D.C.
-
Xanadu and TELUS Collaborate to Advance Quantum Data Centre Infrastructure in Canada
-
Eldorado Gold Announces Receipt of the Operating Authorization for the Ormaque Deposit at the Lamaque Complex
-
Weight Watchers Announces Fourth Quarter and Full Year 2025 Results
-
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the First Quarter of 2026
-
Cielo Announces Strategic Partnership Framework Agreement with Tano T’enneh Enterprises for Proposed Sustainable Aviation Fuel Facility in British Columbia
-
Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026
-
GigaCloud Technology Inc to Participate in 38th Annual Roth Conference
-
Sotera Health Appoints Kenneth D. Krause to the Board of Directors
-
Altus Group Announces Commencement of Substantial Issuer Bid
-
MediciNova to Participate at the 38th Annual ROTH Conference
-
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
-
nCino Launches Doc VOI to Help Lenders Automate Document-based Income Verification
-
Cronos Group Inc. to Speak at the 38th Annual ROTH Conference
-
Heineken N.V. reports the progress of transactions under its current share buyback programme
-
Allot to Participate in the 38th Annual Roth Conference on March 23-24, 2026
-
Minutes from Extraordinary General Meeting
-
iQIYI Files Its Annual Report on Form 20-F
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
Kitron receives a EUR 16 million order for C-UAS ground station equipment.
-
Landsbankinn hf.: End of repurchase period
-
AirSculpt Technologies Announces Its Intent to Delay the Filing of its Annual Report and Provides Business Update
-
Brookfield Business Partners Announces Closing Date of Corporate Simplification
-
Outsourcing provider Yempo Solutions to help UK businesses lower cost of operations, to run roadshow in May 2026
-
Zacatecas Silver Receives Drill Permit for El Cristo, Supporting 2026 Drill Program Aimed at Increasing Existing Silver Resource at the Zacatecas Silver Project
-
Nova Winter Freight Haul Underway
-
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
-
BranchOut to Present at the 38th Annual ROTH Conference During March 23 and 24 at the Ritz Carlton Dana Point
-
Esperion’s Bempedoic Acid Receives Multiple Class 1 Recommendations in 2026 ACC/AHA Multisociety Guideline for Management of Dyslipidemia
-
Super Vision Technology’s i-NYS Implantable Device Approved in China, Breaking the Treatment Barrier for Congenital Nystagmus
